
4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment ...
NEWTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- 4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, unveiled groundbreaking findings at the American Society of Clinical Oncology (ASCO …